Nordic Rare Disease Summit 2025

Name: Nordic Rare Disease Summit 2025
Start: 2025-09-16T08:00:00+02:00
End: 2025-09-17T20:00:00+02:00

16 September @ 8:00 am – 17 September @ 8:00 pm Europe/Copenhagen

The scene has already been set, the roadmap for change is in our hands.

Taking place at the heart of Copenhagen on 16 & 17 September, alongside the Danish Presidency of the European Union, the 2025 Nordic Rare Disease Summit will gather the leading experts within academia and healthcare professionals, patients, decision-makers and industry to discuss solutions; with the joint aspiration of improving the quality of life for people living with rare diseases.

Building on prior summits in 2021 and 2023, the 2025 summit ‘pushing boundaries for rare’ will centre patient empowerment as a key theme.

The expertise of people living with a rare disease must be acknowledged as a resource from the level of individual patients to that of the community, and as a foundation for policymaking in the Nordics and the European Union. Together we can do more.

More Info Here

Event Navigation

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.